Lista de obras -

Altered network connectivity in frontotemporal dementia with C9orf72 hexanucleotide repeat expansion

artículo científico publicado en 2014

Amyloid in dementia associated with familial FTLD: not an innocent bystander

artículo científico publicado en 2015

Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia

scholarly article

Apolipoprotein ε4 is associated with lower brain volume in cognitively normal Chinese but not white older adults

artículo científico publicado en 2015

Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint

scientific article published on 01 January 2020

Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers

artículo científico publicado en 2014

Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

scientific article published on 01 September 2019

Brain volumetric deficits in MAPT mutation carriers: a multisite study

artículo científico publicado en 2020

C9ORF72 repeat expansions in cases with previously identified pathogenic mutations

artículo científico publicado en 2013

C9orf72, AAO and ancestry help discriminating behavioural from language variants in FTLD cohorts

scientific article published on 17 September 2020

Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration

artículo científico publicado en 2020

Clinicopathological correlations in behavioural variant frontotemporal dementia.

artículo científico publicado en 2017

Clinicopathological correlations in corticobasal degeneration

artículo científico publicado en 2011

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease

artículo científico publicado en 2011

Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration

artículo científico publicado en 2020

Distinct Subtypes of Behavioral Variant Frontotemporal Dementia Based on Patterns of Network Degeneration

artículo científico publicado en 2016

Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study

artículo científico publicado en 2014

Erratum to: Network-driven plasma proteomics expose molecular changes in the Alzheimer's brain

artículo científico publicado en 2016

Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases

artículo científico publicado en 2012

Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS

artículo científico publicado en 2011

Frontotemporal dementia and its subtypes: a genome-wide association study

artículo científico publicado en 2014

Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

artículo científico publicado en 2019

Genetic modifiers in carriers of repeat expansions in the C9ORF72 gene

artículo científico publicado en 2014

Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases

artículo científico publicado en 2020

Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD

scientific article published on 09 February 2019

Increased prevalence of autoimmune disease within C9 and FTD/MND cohorts: Completing the picture

scientific article published on 28 October 2016

Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration

artículo científico publicado en 2020

Network degeneration and dysfunction in presymptomatic C9ORF72 expansion carriers

artículo científico publicado en 2016

Network-driven plasma proteomics expose molecular changes in the Alzheimer's brain

artículo científico publicado en 2016

Novel late-onset Alzheimer disease loci variants associate with brain gene expression

artículo científico publicado en 2012

Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C-->T (Arg493X) mutation: an international initiative

artículo científico publicado en 2007

Plasma neurofilament light chain predicts progression in progressive supranuclear palsy

artículo científico publicado en 2016

Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study.

artículo científico publicado en 2018

Quality of life and caregiver burden in familial frontotemporal lobar degeneration: Analyses of symptomatic and asymptomatic individuals within the LEFFTDS cohort

artículo científico publicado en 2020

Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

artículo científico publicado en 2017

Rarity of the Alzheimer disease-protective APP A673T variant in the United States

artículo científico publicado en 2015

TDP-43 frontotemporal lobar degeneration and autoimmune disease

artículo científico publicado en 2013

TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia

scientific article published on 03 January 2014

The longitudinal evaluation of familial frontotemporal dementia subjects protocol: Framework and methodology

scientific article published on 06 January 2020

Tracking white matter degeneration in asymptomatic and symptomatic MAPT mutation carriers

artículo científico publicado en 2019

Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium

scientific article published on 01 January 2020

Lista de obras de

Altered network connectivity in frontotemporal dementia with C9orf72 hexanucleotide repeat expansion

Amyloid in dementia associated with familial FTLD: not an innocent bystander

Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia

Apolipoprotein ε4 is associated with lower brain volume in cognitively normal Chinese but not white older adults

Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint

Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers

Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

Brain volumetric deficits in MAPT mutation carriers: a multisite study

C9ORF72 repeat expansions in cases with previously identified pathogenic mutations

C9orf72, AAO and ancestry help discriminating behavioural from language variants in FTLD cohorts

Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration

Clinicopathological correlations in behavioural variant frontotemporal dementia.

Clinicopathological correlations in corticobasal degeneration

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease

Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration

Distinct Subtypes of Behavioral Variant Frontotemporal Dementia Based on Patterns of Network Degeneration

Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study

Erratum to: Network-driven plasma proteomics expose molecular changes in the Alzheimer's brain

Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases

Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS

Frontotemporal dementia and its subtypes: a genome-wide association study

Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

Genetic modifiers in carriers of repeat expansions in the C9ORF72 gene

Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases

Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD

Increased prevalence of autoimmune disease within C9 and FTD/MND cohorts: Completing the picture

Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration

Network degeneration and dysfunction in presymptomatic C9ORF72 expansion carriers

Network-driven plasma proteomics expose molecular changes in the Alzheimer's brain

Novel late-onset Alzheimer disease loci variants associate with brain gene expression

Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C-->T (Arg493X) mutation: an international initiative

Plasma neurofilament light chain predicts progression in progressive supranuclear palsy

Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study.

Quality of life and caregiver burden in familial frontotemporal lobar degeneration: Analyses of symptomatic and asymptomatic individuals within the LEFFTDS cohort

Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

Rarity of the Alzheimer disease-protective APP A673T variant in the United States

TDP-43 frontotemporal lobar degeneration and autoimmune disease

TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia

The longitudinal evaluation of familial frontotemporal dementia subjects protocol: Framework and methodology

Tracking white matter degeneration in asymptomatic and symptomatic MAPT mutation carriers

Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium